Style | Citing Format |
---|---|
MLA | S Sarejloo SHIRIN, et al.. "Diagnostic and Prognostic Role of Nlr in Testicular Cancer." Exploration of Targeted Anti-tumor Therapy, vol. 5, no. , 2024, pp. 1177-1198. |
APA | S Sarejloo SHIRIN, S Babadi SAGHAR, S Khanzadeh SHOKOUFEH, A Salimi AMIRHOSSEIN, A Clark ALEC, D Khazaeli DINYAR, M Khanzadeh MONIREH, A Ghaedi ARSHIN, Bp Luckewold Brandon PETER (2024). Diagnostic and Prognostic Role of Nlr in Testicular Cancer. Exploration of Targeted Anti-tumor Therapy, 5(), 1177-1198. |
Chicago | S Sarejloo SHIRIN, S Babadi SAGHAR, S Khanzadeh SHOKOUFEH, A Salimi AMIRHOSSEIN, A Clark ALEC, D Khazaeli DINYAR, M Khanzadeh MONIREH, A Ghaedi ARSHIN, Bp Luckewold Brandon PETER. "Diagnostic and Prognostic Role of Nlr in Testicular Cancer." Exploration of Targeted Anti-tumor Therapy 5, no. (2024): 1177-1198. |
Harvard | S Sarejloo SHIRIN et al. (2024) 'Diagnostic and Prognostic Role of Nlr in Testicular Cancer', Exploration of Targeted Anti-tumor Therapy, 5(), pp. 1177-1198. |
Vancouver | S Sarejloo SHIRIN, S Babadi SAGHAR, S Khanzadeh SHOKOUFEH, A Salimi AMIRHOSSEIN, A Clark ALEC, D Khazaeli DINYAR, et al.. Diagnostic and Prognostic Role of Nlr in Testicular Cancer. Exploration of Targeted Anti-tumor Therapy. 2024;5():1177-1198. |
BibTex | @article{ author = {S Sarejloo SHIRIN and S Babadi SAGHAR and S Khanzadeh SHOKOUFEH and A Salimi AMIRHOSSEIN and A Clark ALEC and D Khazaeli DINYAR and M Khanzadeh MONIREH and A Ghaedi ARSHIN and Bp Luckewold Brandon PETER}, title = {Diagnostic and Prognostic Role of Nlr in Testicular Cancer}, journal = {Exploration of Targeted Anti-tumor Therapy}, volume = {5}, number = {}, pages = {1177-1198}, year = {2024} } |
RIS | TY - JOUR AU - S Sarejloo SHIRIN AU - S Babadi SAGHAR AU - S Khanzadeh SHOKOUFEH AU - A Salimi AMIRHOSSEIN AU - A Clark ALEC AU - D Khazaeli DINYAR AU - M Khanzadeh MONIREH AU - A Ghaedi ARSHIN AU - Bp Luckewold Brandon PETER TI - Diagnostic and Prognostic Role of Nlr in Testicular Cancer JO - Exploration of Targeted Anti-tumor Therapy VL - 5 IS - SP - 1177 EP - 1198 PY - 2024 ER - |